| Astrazeneca Pharma India Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 506820 |
NSE Symbol : ASTRAZEN |
P/E(TTM) : 85.65 |
|
ISIN Demat : INE203A01020 |
Div & Yield% : 0.61 |
EPS(TTM) : 69.39 |
|
Book Value(₹) : 349.12 |
Market Cap(₹Cr) : 14,858.75 |
Face Value(₹) : 2.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 682.79 | 578.61 | 611.57 | 559.09 | 526.31 | 480.48 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 682.79 | 578.61 | 611.57 | 559.09 | 526.31 | 480.48 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 9.23 | 5.95 | 6.61 | 6.17 | 11.24 | 16.15 |
| Total Income | 692.02 | 584.56 | 618.18 | 565.26 | 537.55 | 496.63 |
| Total Expenditure | 634.09 | 518.78 | 566.74 | 489.20 | 445.56 | 399.79 |
| PBIDT | 57.93 | 65.78 | 51.44 | 76.06 | 91.99 | 96.84 |
| Interest | 1.95 | 2.04 | 1.06 | 0.67 | 0.72 | 0.68 |
| PBDT | 55.98 | 63.74 | 50.38 | 75.39 | 91.27 | 96.16 |
| Depreciation | 5.23 | 5.60 | 3.84 | 2.57 | 16.57 | 17.69 |
| Tax | 10.87 | 14.31 | 4.00 | 19.01 | 22.10 | 22.92 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 1.95 | -1.05 | 9.95 | -0.41 | -3.23 | -2.70 |
| Reported Profit After Tax | 37.93 | 44.88 | 32.59 | 54.22 | 55.83 | 58.25 |
| Extra-ordinary Items | -0.18 | -0.81 | 1.04 | -3.91 | -0.25 | -4.02 |
| Adjusted Profit After Extra-ordinary item | 38.11 | 45.69 | 31.55 | 58.13 | 56.08 | 62.27 |
| EPS (Unit Curr.) | 15.17 | 17.95 | 13.04 | 21.69 | 22.33 | 23.30 |
| EPS (Adj) (Unit Curr.) | 15.17 | 17.95 | 13.04 | 21.69 | 22.33 | 23.30 |
| Calculated EPS (Unit Curr.) | 15.17 | 17.95 | 13.04 | 21.69 | 22.33 | 23.30 |
| Calculated EPS (Adj) (Unit Curr.) | 15.17 | 17.95 | 13.04 | 21.69 | 22.33 | 23.30 |
| Calculated EPS (Ann.) (Unit Curr.) | 60.69 | 71.81 | 52.14 | 86.75 | 89.33 | 93.20 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 60.69 | 71.81 | 52.14 | 86.75 | 89.33 | 93.20 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 8.48 | 11.37 | 8.41 | 13.60 | 17.48 | 20.15 |
| PBDTM(%) | 8.20 | 11.02 | 8.24 | 13.48 | 17.34 | 20.01 |
| PATM(%) | 5.56 | 7.76 | 5.33 | 9.70 | 10.61 | 12.12 |
